References
- Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005;85:1–31
- Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008;75:346–59
- Obesity and Overweight. World Health Organization global strategy on diet, physical activity and health. http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/
- Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 2006;29:109–17
- Tchernof A, Poehlman ET, Després JP. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab 2000;26:12–20
- Ozbey N, Sencer E, Molvalilar S, Orhan Y. Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI. Endocr J 2002;49:503–9
- Miksztowicz V, Muzzio ML, Royer M, . Increased plasma activity of metalloproteinase 2 in women with metabolic syndrome. Metabolism 2008;57:1493–6
- Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006;55:1537–45
- Berg G, Miksztowicz V, Schreier L. Metalloproteinases in metabolic syndrome. Clin Chim Acta 2011;412:1731–9
- Assmann G, Schriewer H, Schmitz G, Hägele EO. Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clin Chem 1983;29:2026–30
- Assmann G, Jabs HU, Kohnert U, Nolte W, Schriewer H. LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate. Clin Chim Acta 1984;140:77–83
- Warnick GR. Measurement and clinical significance of high density lipoprotein cholesterol: subclasses. In Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of Lipoprotein Testing. AACC Press, 1997:251–66
- Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994;218:325–9
- Berg G, Mesch V, Boero L, . Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution. Horm Metab Res 2004;36:215–20
- Shi H, Clegg DJ. Sex differences in the regulation of body weight. Physiol Behav 2009;97:199–204
- Mesch VR, Boero LE, Siseles NO, . Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric 2006;9:40–8
- Després JP, Lemieux I, Bergeron J, . Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008;28: 1039–49
- Sowers M, Derby C, Jannausch ML, Torrens JI, Pasternak R. Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN. J Clin Endocrinol Metab 2003;88:4904–10
- Christodoulakos GE, Panoulis CP, Lambrinoudaki IV, . The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women. Menopause 2004;11:299–305
- Wakatsuki A, Ikenoue N, Shinohara K, Watanabe K, Fukaya T. Different effects of oral and transdermal estrogen replacement therapy on matrix metalloproteinase and their inhibitor in postmenopausal women. Arterioscler Thromb Vasc Biol 2003;23: 1948–9
- Montero I, Orbe J, Varo N, . C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 2006;47:1369–78
- Cheng KH, Chu CS, Lee KT, . Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008;32:268–74
- Milewicz A, Jedrzejuk D, Dunajska K, Lwow F. Waist circumference and serum adiponectin levels in obese and non-obese postmenopausal women. Maturitas 2010;65:272–5
- Kumada M, Kihara S, Ouchi N, . Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004;109:2046–9
- Vaiopoulos AG, Marinou K, Christodoulides C, Koutsilieris M. The role of adiponectin in human vascular physiology. Int J Cardiol 2012;155:188–93
- Gummesson A, Hagg D, Olson FJ, Hulthe J, Carlsson LM, Fagerberg B. Adipose tissue is not an important source for matrix metalloproteinase-9 in the circulation. Scand J Clin Lab Invest 2009;69:636–42